Trending now:  
TRILUMINATE: Transcatheter repair of tricuspid regurgitation
Top highlights from ACC 2023
Hemodynamic instability not predictive of fatal outcomes in non-STEMI out-of-hospital cardiac arrest
Gross national income impacts European Society of Cardiology guideline applicability
Clinical outcomes with FFR-guided PCI of non-culprit lesions in acute MI

Podcast |

iMODERN: When to treat non-culprit lesions in STEMI

30 Aug 2022
Cardiology Update
Cardiology Update
iMODERN: When to treat non-culprit lesions in STEMI

The iMODERN trial (“iFR Guided Multi-vessel Revascularization During Percutaneous Coronary Intervention for Acute Myocardial Infarction.”) trial is an ongoing multinational study. This study will provide important knowledge on the best practice for the assessment and treatment of multi-vessel disease involving ST-segment elevation myocardial infarction (STEMI) patients.

We spoke with Professor Robin Nijveldt, Cardiologist at Radboud University Medical Center in Nijmegen, the Netherlands about this ongoing prospective, randomized controlled, multicentre study.

Learn more at

For more cardiology research news, join Cardiology Update on FacebookTwitterLinkedIn or Instagram.

Keywords: cardiology, cardiologist, heart, medicine, doctor, cardiology-update